Abstract
Patients suffering from hip osteoarthritis (OA) are frequently symptomatic, and the disease can result in significant limitation of patients’ activity and high social costs. Hip OA is generally managed with systemic treatments such as nonsteroidal anti-inflammatory drugs (NSAIDs) and/or symptomatic slow acting drugs. Viscosupplementation with hyaluronan (HA) or its derivatives, which aims to restore the physiological and rheological features of the synovial fluid to improve symptoms, is now a routinely prescribed treatment for OA of the knee. However, few data exist in the literature regarding the use of viscosupplementation in the treatment of hip OA. The objective of this prospective, open, uncontrolled pilot study was to investigate the safety and effectiveness of intra-articular injection, under ultrasound control, of hylan G-F 20 for the treatment of OA of the hip. Twelve patients (≥40 years old) with symptomatic hip OA were treated with one injection of 2 ml of hylan G-F 20 under ultrasound guidance. During the study, patients were evaluated for safety and efficacy using the Lequesne index, a visual analogue scale (VAS) measure of hip OA pain and analysis of NSAID consumption. Patients treated with hylan G-F 20 in this study showed clinically significant reductions in Lequesne and VAS scores and in the consumption of NSAIDs up to 3 months after the injection. In the 12 patients treated (total of 14 injections), no systemic adverse events were observed. Three patients reported mild, local pain post-injection. This study demonstrates the potential of ultrasound-guided intra-articular injections of a viscosupplement into the hip joint and gives positive preliminary information about the safety and efficacy of hylan G-F 20 for the treatment of symptomatic hip OA.
Similar content being viewed by others
References
Altman RD, Hochberg MC, Moskowitz RW, Schnitzer TJ (2000) Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 43:1905–1915
Sturkenboom MC, Romano F, Simon G, Correa-Leite ML, Villa M, Nicolosi Á, Borgnolo G, White-Porro G, Mannino S (2002) The iatrogenic costs of NSAID therapy: a population study. Arthritis Rheum 47:132–140
Wobig M, Dickhut A, Maier R, Vetter G (1998) Viscosupplementation with hylan G-F 20: a six-month controlled trial of efficacy and safety in the osteoarthritic knee. Int J Drug Ther 20:410–423
Dickson DJ, Hosie G, English JR et al (2001) A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res 4:41–52
Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, de Medicis R (1996) Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 23:1579–1585
Marshall KW (1997) The current status of hylan therapy for the treatment of osteoarthritis. Today’s Ther Trends 15:99–108
Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N (2002) A prospective, randomized, pragmatic health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage 10:506–517
Bragantini Á, Molinaroli F (1994) A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Curr Ther Res Clin Exp 55:319–330
Qvistgaard E, Kristoffersen H, Terslev L, Danneskiold-Samsoe B, Torp-Pedersen S, Bliddal H (2001) Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthritis Cartilage 9:512–517
Brocq O, Tran G, Breuil V, Grisot C, Flory P, Euller-Ziegler L (2002) Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 69:388–391
Conrozier T, Bertin P, Mathieu P, Charlot J, Bailleul F, Trèves R et al (2003) Intra-articular injections of hylan GF-20 in patients with symptomatic hip osteoarthritis: an open-label, multi-centre pilot study. Clin Exp Rheumatol 21:605–610
Jones A, Regan M, Ledingham J, Pattrick M, Manhire A, Doherty M (1993) Importance of placement of intra-articular steroid injections. BMJ 307:1329–1330
Jackson DW, Evans NA, Thomas BM (2002) Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 84A: 1522–1527
Migliore A, Martin Martin LS, Alimonti A et al (2003) Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 11:305–306
Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K et al (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505-514
Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthrosis. Ann Rheum Dis 16:494-502
Lequesne MG (1997) The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 24:779–781
Scott-Huskisson EC (1976) Graphic representation of pain. Pain 2:175–184
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Migliore, A., Tormenta, S., Martin, L.S.M. et al. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol 24, 285–289 (2005). https://doi.org/10.1007/s10067-004-1009-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-004-1009-1